Recombinant factor VIIa should be used in massive obstetric haemorrhage

International Journal of Obstetric Anesthesia

Volumn 16, Issue 4, 2007, Pages 357-359

  Van de Velde, M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Activated recombinant factor seven; Caesarean section; Obstetric anaesthesia; rFVIIa

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COST; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; NECROTIZING ENTEROCOLITIS; OBSTETRIC HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; VENOUS THROMBOEMBOLISM;

COAGULANTS; EVIDENCE-BASED MEDICINE; FACTOR VIIA; FEMALE; GREAT BRITAIN; HEMOPHILIA A; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS; RECOMBINANT PROTEINS;

EID: 34548480219     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2007.06.002     Document Type: Article

References (13)

1. Confidential Enquiry into Maternal and Child Health. Why mothers die 2000-2002. London: RCOG Press; 86-95.
2. Franchini M., Zaffanello M., and Veneri D. Recombinant factor VIIa, an update on its clinical use. Thromb Haemost 93 (2005) 1027-1035
3. Rott H., Trobisch H., and Kretzschmar E. Use of recombinant factor VIIa, Novo seven, in the management of acute haemorrhage. Curr Opin Anaesthesiol 17 (2004) 159-163
4. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352 (2005) 777-785
5. Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterelogy 127 (2004) 1123-1130
6. Haynes J., Laffan M., and Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 16 (2007) 40-49
7. Laffan M, O'Connell NM, Perry DJ, Hodgson AJ, O'Shaughnessy D, OP Smith. Analysis and results of the recombinant factor VIIa extended-use registry. Blood Coagul Fibrinolysis 2003;14:S35-8.
8. Akyildiz M., Turan I., Ozutemiz O., Batur Y., and Ilter T. A cerebrovascular event after single-dose administration of recombinent factor VIIa in a patient with esophageal variceal bleeding. Dig Dis Sci 51 (2006) 1647-1649
9. Basso I.N., and Keeling D. Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease. Blood Coagul Fibrinolysis 15 (2004) 503-504
10. de Jonge E., Friederich P.W., Vlasuk G.P., et al. Activation of coagulation by administration of recombinant factor VIIa elicits interleuking 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diag Lab Immunol 10 (2003) 495-497
11. McCall P., Story D.A., and Karapillai D. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth 53 (2006) 926-933
12. Ahonen J., and Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Brit J Anaesth 94 (2005) 592-595
13. Esler M.D., and Douglas M.J. Planning for hemorrhage: Steps an anesthesiologist can take to limit and treat hemorrhage in the obstetric patient. Anesthesiology Clin N Am 21 (2003) 127-144